Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1372093 | Bioorganic & Medicinal Chemistry Letters | 2010 | 6 Pages |
Abstract
Herein we describe the discovery of a novel series of pyrrolo[1,2-a]pyrazin-1(2H)-one PARP inhibitors. Optimization led to compounds that display excellent PARP-1 enzyme potency and inhibit the proliferation of BRCA deficient cells in the low double-digit nanomolar range showing excellent selectivity over BRCA proficient cancer cells.
Graphical abstractThe discovery and optimization of a novel series of pyrrolo[1,2-a]pyrazin-1(2H)-one PARP inhibitors is reported, leading to potent inhibitors displaying excellent anti-proliferation activity in BRCA deficient cells.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Giovanna Pescatore, Danila Branca, Fabrizio Fiore, Olaf Kinzel, Laura Llauger Bufi, Ester Muraglia, Federica Orvieto, Michael Rowley, Carlo Toniatti, Caterina Torrisi, Philip Jones,